Intrinsic Value of S&P & Nasdaq Contact Us

InfuSystem Holdings, Inc. INFU NYSE

NYSE • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
78/100
5/7 Pass
SharesGrow Intrinsic Value
$18.65
+86.7%
Analyst Price Target
$15.00
+50.2%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

InfuSystem Holdings, Inc. (INFU) trades at a trailing P/E of 28.6, forward P/E of 24.0. Trailing earnings yield is 3.49%, forward earnings yield 4.16%. PEG 0.16 (Peter Lynch undervalued ≤1.0). Graham Number is $4.55.

Criteria proven by this page:

  • VALUE (78/100, Pass) — PEG ≤ 1.0 — Peter Lynch undervalued (0.16); analyst target implies upside (+50.2%).
  • Forward P/E 24.0 (down from trailing 28.6) — analysts expect earnings to grow, which would improve the valuation.
  • PEG Ratio 0.16 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield 3.49% — roughly competitive with bond yields (~4.3%), moderate risk-reward. Forward yield improves to 4.16% as earnings recover.
  • Analyst consensus target $15.00 (+50.2% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 78/100 with 5/7 criteria passed.

SharesGrow 7-Criteria Score
78/100
SG Score
View full scorecard →
VALUE
78/100
Price-to-Earnings & upside
Proven by this page
FUTURE
100/100
Analyst consensus
→ Forecast
PAST
100/100
→ Income
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
54/100
→ Income
GROWTH
83/100
→ Income
INCOME
30/100
→ Income

Valuation Snapshot — INFU

Valuation Multiples
P/E (TTM)28.6
Forward P/E24.0
PEG Ratio0.16
Forward PEG0.70
P/B Ratio3.31
P/S Ratio1.33
EV/EBITDA7.5
Per Share Data
EPS (TTM)$0.33
Forward EPS (Est.)$0.42
Book Value / Share$2.82
Revenue / Share$7.07
FCF / Share$1.12
Yields & Fair Value
Earnings Yield3.49%
Forward Earnings Yield4.16%
Dividend Yield0.00%
Graham Number$4.55
SharesGrow IV$18.65 (+86.7%)
Analyst Target$15.00 (+50.2%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 -255.0 2.41 1.12 0.80 -
2017 -2.5 0.00 1.69 0.74 -
2018 -67.3 0.71 3.60 1.10 -
2019 123.7 -0.53 7.54 2.07 -
2020 21.8 0.02 9.27 3.88 -
2021 246.1 -2.68 7.24 3.41 -
2022 9,957.3 -100.87 3.73 1.63 -
2023 254.1 0.06 4.24 1.76 -
2024 76.7 0.44 3.12 1.33 -
2025 28.0 0.15 3.23 1.29 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $-0.01 $70.5M $-222K -0.3%
2017 $-0.91 $71.08M $-20.71M -29.1%
2018 $-0.05 $67.14M $-1.1M -1.6%
2019 $0.07 $81.12M $1.36M 1.7%
2020 $0.80 $97.39M $17.33M 17.8%
2021 $0.06 $102.38M $1.42M 1.4%
2022 $0.00 $109.91M $18K 0%
2023 $0.04 $125.79M $872K 0.7%
2024 $0.11 $134.86M $2.35M 1.7%
2025 $0.31 $143.44M $6.63M 4.6%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $0.42 $0.39 – $0.44 $145.13M $144.83M – $145.42M 4
2027 $0.52 $0.45 – $0.59 $155.74M $153.32M – $158.15M 4
2028 $0.00 $0.00 – $0.00 $165.2M $163.58M – $167.44M 3
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message